摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

氯菊酯 | 52645-53-1

中文名称
氯菊酯
中文别名
(3-苯氧苄基)甲基顺式,反式(±)-3-(2,2-二氯乙烯基)-2,2-二甲基环丙烷羧酸酯;除虫精;氯菊脂;95%氯菊酯原药;3-苯氧基苄基-2,2-二甲基-3-(2,2-二氯乙烯基)-1-环丙烷羧酸酯;(1R,S)-顺,反式-2,2-二甲基-3-(2,2-二氯乙烯基)-环丙烷羧酸-3-苯氧基苄基酯;3-苯氧基苄基(1RS)-顺-反-3-(2,2-二氯乙烯基-2,2-二甲基环丙烷羧酸酯;3-苯氧基苄基 (1RS,3RS;二氯苯醚菊酯;苄氯菊酯;3-苯氧基苄基(1RS,3RS
英文名称
permethrin
英文别名
3-phenoxybenzyl (1RS)-cis,trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate;(3-phenoxyphenyl)methyl 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate;3-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate;3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylic acid (3-phenoxyphenyl)methyl ester;NRDC143;(+/-)-cis,trans-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylic acid (3-phenoxyphenyl)methyl ester;(3-phenoxyphenyl)methyl 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate
氯菊酯化学式
CAS
52645-53-1
化学式
C21H20Cl2O3
mdl
MFCD00041809
分子量
391.294
InChiKey
RLLPVAHGXHCWKJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    34-35°C
  • 沸点:
    bp0.05 220°
  • 密度:
    1.19
  • 闪点:
    10 °C
  • 溶解度:
    DMF:33mg/mL; DMSO:16mg/mL;乙醇:14mg/mL
  • LogP:
    6.500
  • 物理描述:
    Permethrin is a pale brown liquid. Relatively water insoluble. Used as an insecticide.
  • 颜色/状态:
    Colorless crystals to a viscous liquid; Color, white to pale yellow
  • 蒸汽压力:
    5.18X10-8 mm Hg at 25 °C (OECD Method 104)
  • 稳定性/保质期:

    对兔皮肤无刺激作用,但对眼睛有轻微刺激作用。大鼠体内蓄积性较小,动物试验中未发现该物质具有致畸、致癌或致突变的作用。

  • 分解:
    When heated to decomp it emits toxic fumes of /hydrogen chloride/.
  • 腐蚀性:
    Does not corrode aluminum

计算性质

  • 辛醇/水分配系数(LogP):
    6.5
  • 重原子数:
    26
  • 可旋转键数:
    7
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.285
  • 拓扑面积:
    35.5
  • 氢给体数:
    0
  • 氢受体数:
    3

ADMET

代谢
通过酯解迅速代谢为无活性代谢物,主要通过尿液排出。
Rapidly metabolized by ester hydrolysis to inactive metabolites which are excreted primarily in the urine.
来源:DrugBank
代谢
当四种(14)C-制剂,即(IRS)-反式-、(IR)-反式-、(IRS)-顺式和(IR)-顺式-氯菊酯,在醇和酸部分标记,并以1.6-4.8 mg/kg的剂量口服给雄性大鼠时,这些化合物被迅速代谢,酸和醇部分中的(14)C在几天内几乎完全从体内消除……反式和顺式氯菊酯异构体的主要代谢反应是酸部分的Gem-二甲基组的反式和顺式部分以及醇部分的2'-和4'-位置的氧化,酯键断裂,以及由此产生的羧酸、醇和葡萄糖醛酸、甘酸和硫酸的共轭。顺式异构体比反式异构体更稳定,顺式异构体产生了四种粪便酯代谢物,这些代谢物是由苯氧基团的2'-和4'-位置、反式甲基组和后两个位置的合作用产生的。酯断裂的代谢物大量随尿液排出,而保留酯键的代谢物仅在粪便中找到。(IRS)-异构体和(IR)-异构体在代谢上没有显著差异。
When the four (14)C-preparations of (IRS)-trans-, (IR)-trans- , (IRS)-cis, and (IR)-cis-permethrin labeled in the alcohol and acid moieties were administered orally to male rats at 1.6-4.8 mg/kg, the compounds were rapidly metabolized and the (14)C from the acid and alcohol moeity was almost completely eliminated from the body within a few days. ... The major metabolic reactions of both permethrin isomers /(trans and cis)/ were oxidation at the trans and cis portions of the gem-dimethyl group of the acid moiety and at the 2'- and 4'-positions of the alcohol moiety, ester cleavage, and the conjugation of the resulting carboxylic acids, alcohols, and phenols with glucuronic acid, glycine, and sulfuric acid. The cis isomer is more stable than the tans isomer, and the cis isomer yielded four fecal ester metabolites which resulted from hydroxylation at the 2'- and 4'-positions of the phenoxy group, at the trans- methyl group, and at both of the two latter sites. The ester-cleaved metabolites were extensively excreted into the urine, whereas the metablites retaining ester linkage were found only in the feces. There were no significant differences in metabolism between the (IRS)-isomers and (IR)-isomers.
来源:Hazardous Substances Data Bank (HSDB)
代谢
当白来航鸡连续三天口服四种(14)C-反式和顺式permethrin异构体中的一种,标记在醇或酸中的10毫克/千克体重时,它们没有出现中毒迹象。在初次给药后9天,从四种标记的制剂中发现了超过87%的放射性碳,0.7-4.7%的剂量以(14)CO2的形式呼出,0.12-0.47%和0.06-0.66%的放射性碳分别在蛋黄和脂肪(皮下和内脏脂肪)中回收。在醇和酸部分标记的顺式异构体在脂肪和蛋黄中的回收率比相应的反式异构体高3到>10倍。排泄物(0-72小时)中含有1.7倍的顺式permethrin比反式permethrin多。反式permethrin的羟基化酯代谢物没有排出,但发现了顺式permethrin的四种单羟基和二羟基酯(即trans-OH-permethrin,4'-OH-permethrin,4'-OH,trans-OH-permethrin和trans-OH-permethrin硫酸盐)。来自两种异构体酸部分的代谢物是Cl2CA异构体的自由、葡萄糖醛酸苷和牛磺酸结合形式,trans-OH-Cl2CA,cis-OH-Cl2CA,cis-OH-Cl2CA内酯和cis-OH-Cl2CA硫酸盐。从顺式异构体得到的trans-OH-Cl2CA比从反式异构体得到的量要大,而与顺式异构体相比,反式异构体的cis-OH-Cl2-CA的量要大。来自醇部分的代谢物包括PBalc,PBacid,它们的4'-羟基衍生物和相应的硫酸盐,PBalc的葡萄糖醛酸苷,以及4'-OH-PBalc和4'-OH-PBacid的各种未识别的共轭物。没有检测到PBacid的牛磺酸共轭物。产生量最大的代谢物是4'-OH-PBalc(剂量的6-13%)和4'-OH-PBacid(2-11%)的未识别共轭物。初次给药后5天和6天的蛋黄中含有4.4倍的顺式perethrin,未变化的反式perethrin和与排泄物中发现的相同的顺式permethrin酯代谢物。蛋黄中的其他代谢物通常与排泄物中的相同。总体而言,顺式permethrin在蛋黄、脂肪组织和排泄物中的平高于反式permethrin。来自顺式permethrin制剂的放射性碳在血液中也比来自反式permethrin制剂的放射性碳持续的时间更长。这可能是由于反式异构体的酯解比顺式异构体更快,基于两种异构体在鸡排泄物中解产物的相对量。
When White Leghorn hens were treated orally three consecutive days with one of four (14)C-trans- and cis-permethrin isomers labelled in the alcohol or acid at 10 mg/kg body weight, they showed no signs of poisoning. More than 87% of the radiocarbon from the four labelled perparations was found in the excreta 9 days after the initial dose, 0.7-4.7% of the dose was exhaled as (14)CO2, and 0.12-0.47% and 0.06-0.66% of the radiocarbon was recovered in egg yolk and fat (subcutaneous and visceral fat), respectively. Both the cis isomers labelled in the alcohol and acid moieties showed recoveries 3 to >10 times higher in the fat and egg yolk than those shown by the corresponding trans isomers. The excreta (0-72 hr) contained 1.7 times more cis-permethrin than trans-permethrin. Hydroxylated ester metabolites of trans-permethrin were not excreted, but four monohydroxy and dihydroxy esters (i.e. trans-OH-permethrin, 4'-OH-permethrin, 4'-OH, trans-OH-permethrin and trans-OH-permethrin sulfate) of cis-permethrin were found. Metabolites from the acid moieties of both isomers were the Cl2CA isomers in free, glucuronide, and taurine conjugate forms, trans-OH-Cl2CA, cis-OH-Cl2CA, cis-OH-Cl2CA lactone, and cis-OH-Cl2CA sulfate. trans-OH-Cl2CA was obtained from the cis isomer to larger extents than from the trans isomer, whereas the amounts of cis-OH-Cl2-CA were larger with the trans isomer than with the cis isomer. The metabolites from the alcohol moiety included PBalc, PBacid, their 4'-hydroxy-derivatives and the corresponding sulfate the glucuronide of PBalc, and a variety of unidentified conjugates of 4'-OH-PBalc and 4'-OH-PBacid. The taurine conjugate of PBacid was not detected. The metabolites produced in largest amounts were the unidentified conjugates of 4'-OH-PBalc (6-13% of the dose) and 4'-OH-PBacid (2-11%). The yolk of eggs 5 and 6 days after initial dosing contained 4.4 times cis-perethrin than trans-permethrin in unchanged form and the same ester metabolites of cis-permethrin as those found in the excreta. Other metabolites in the yolk were generally the same as those in the excreta. Overall, cis-permethrin appeared at higher levels than trans-permethrin in the egg yolk, fatty tissues, and excreta. Radiocarbon from cis-permethrin preparations also persisted longer in the blood than that from trans-permethrin preparations. It probably resulted from more rapid ester cleavage of the trans isomer than the cis isomer, based on the relative amounts of hydrolysis products form the two isomers in hen excreta.
来源:Hazardous Substances Data Bank (HSDB)
代谢
两名人类志愿者分别摄入了大约2毫克和4毫克的氯菊酯(25:75比例),在收集的24小时尿液经过酸解后,检测到作为代谢物Cl2CA排出了18-37%和32-39%的给药剂量。
Two human volunteers, who consumed about 2 and 4 mg of permethrin (25:75), respectively, excreted 18-37% and 32-39% of the administered dose, detected as the metabolite Cl2CA, after acid hydrolysis of their urine collected over 24 hr.
来源:Hazardous Substances Data Bank (HSDB)
代谢
羊体内的permethrin代谢物是通过酯键的断裂、顺式或反式甲基的羟基化以及苯氧基苄基的4'-位置的羟基化形成的。其中一些代谢产物进一步被氧化和/或与甘酸、谷酸和葡萄糖醛酸结合。在给羊投喂顺式permethrin后,粪便中的主要化合物是未代谢的母化合物4'-OH-permethrin、trans-OH-permethrin、PBalc、cis-OH-cis-Cl2CA-lactone和八种未识别的酯代谢物。投喂反式异构体的羊的粪便中含有大量母化合物(粪便中(14)C的41-79%和PBalc的8-25%)以及cis-OH-trans-Cl2CA-lactone。还发现了三种未识别的酯代谢物(8-23%)。另一方面,两个异构体的醇部分的主要尿液代谢物是PBacid-glycine(尿液中(14)C的7-9%)和r'-OH-PBacid-glycine(4-12%)。PBalc、PBacid、4'-OH-PBalc、4'-OH-PBacid、PBacid-glutamic acid和4'-OH-PBacid-glutamic acid也被鉴定为次要代谢物。投喂两个异构体的羊的尿液中主要成分是Cl2CA的游离形式(尿液中(14)C的2-4%)和作为葡萄糖苷酸的形式(27-71%)。与顺式异构体相比,反式异构体得到了更大程度的Cl2CA-glucuronide。顺式异构体的其他主要代谢物是cis-OH-Cl2CA(33)(9-11%)和cis-OH-cis-Cl2CA-lactone(11-16%)。trans-OH-Cl2CA被检测为两个异构体的次要代谢物。羊奶中含有母化合物、PBacid-glycine和4'-OH-PBacide-glycine。在投喂顺式异构体时,奶中排出了大量的母化合物,比投喂反式异构体时要多。相比之下,当投喂反式异构体时,PBacid-glycine在奶中的检测程度比顺式异构体要大。脂肪中的大部分放射性归因于母化合物或酯代谢物,如trans-OH-permethrin和trans-OH-permethrin结合物。
The permethrin metabolites in goats were formed through cleavage of the ester linkage, hydroxylation at the cis- or trans-methyl of the geminal dimethyl group, and hydroxylation at the 4'-position of the phenoxybenzyl moiety. Some of these metabolic products were further oxidized and/or conjugated with glycine, glutamic acid and glucuronic acid. The major compounds found in feces after dosing with cis-permethrin were unmetabolized parent compound 4'-OH-permethrin, trans-OH-permethrin, PBalc, cis-OH-cis-Cl2CA-lactone and eight unidentified ester metabolites. The feces of goats treated with the trans isomer contained large amounts of the parent compound (41-79% of the fecal (14)C and of PBalc (8-25%) and cis-OH-trans-Cl2CA-lactone. Also, three unidentified ester metabolites were found (8-23%). On the other hand, major urinary metabolites from the alcohol moiety of both isomers were PBacid-glycine (7-9% of the urinary (14)C) and r'-OH-PBacid-glycine (4-12%). PBalc, PBacid, 4'-OH-PBalc, 4'-OH-PBacid, PBacid-glutamic acid and 4'-OH-PBacid-glutamic acid were also identified as minor metabolites. The urine of goats treated with both isomers contained as major components, Cl2CA in the free form (2-4% of the urinary (14)C) and as a glucuronide (27-71%). Cl2CA-glucuronide was obtained to a larger extent with the trans isomer than with the cis isomer. Other major metabolites of the cis isomer were cis-OH-Cl2CA (33) (9-11%) and cis-OH-cis-Cl2CA-lactone (11-16%). trans-OH-Cl2CA was detected as a minor metabolite of both isomers. The milk of goats contained the parent compounds, PBacid-glycine, and 4'-OH-PBacide-glycine. On administration of the cis isomer, a large amount of the parent compund was excreted in the milk than in the case of the trans isomer. Comparatively, when the trans isomer was administered, PBacid-glycine was detected in the milk to a larger extent than with the cis isomer. Most of the radioactivity in the fat was attributed to the parent compound or ester metabolites such as trans-OH-permethrin and trans-OH-permethrin conjugate.
来源:Hazardous Substances Data Bank (HSDB)
毒理性
  • 毒性总结
除虫菊酯类农药通过延长神经细胞兴奋时通道门的开启相来发挥其作用。它们似乎与通道附近的膜脂质相结合,从而改变通道动力学。这阻止了神经中通道的关闭,从而延长了膜电位恢复到静息状态的时间。重复的(感觉、运动)神经元放电和延长的负后电位产生的效果与DDT产生的效果非常相似,导致神经系统过度活跃,可能导致瘫痪和/或死亡。拟除虫菊酯类农药的其他作用机制包括对抗γ-丁酸GABA)介导的抑制、调节尼古丁乙酰胆碱能传递、增强去甲肾上腺素的释放以及对钙离子的作用。(T18, L857)
Pyrethroids exert their effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. They appear to bind to the membrane lipid phase in the immediate vicinity of the sodium channel, thus modifying the channel kinetics. This blocks the closing of the sodium gates in the nerves, and thus prolongs the return of the membrane potential to its resting state. The repetitive (sensory, motor) neuronal discharge and a prolonged negative afterpotential produces effects quite similar to those produced by DDT, leading to hyperactivity of the nervous system which can result in paralysis and/or death. Other mechanisms of action of pyrethroids include antagonism of gamma-aminobutyric acid (GABA)-mediated inhibition, modulation of nicotinic cholinergic transmission, enhancement of noradrenaline release, and actions on calcium ions. (T18, L857)
来源:Toxin and Toxin Target Database (T3DB)
毒理性
  • 致癌性证据
美国环保局将permethrin归类为“可能对人类有致癌性”,这一分类是基于在小鼠中可复现的两种良性肿瘤类型(肺和肝脏),在长艾文大鼠中致癌性的不明确证据,以及支持的结构-活性关系(SAR)信息。为了进行风险评估,使用了低剂量外推模型(Q1*)。Q1*值为9.6 x 10-3 (mg/kg/天)-1,来源于雌性小鼠肺部(腺瘤和/或癌瘤)肿瘤。
The /Environmental Protection/ Agency classified permethrin as "Likely to be Carcinogenic to Humans" by the oral route. This classification was based on two reproducible benign tumor types (lung and liver) in the mouse, equivocal evidence of carcinogenicity in Long-Evans rats, and supporting structural activity relationships (SAR) information. For the purpose of risk characterization, a low dose extrapolation model (Q1*) was used. The Q1* is 9.6 x 10-3 (mg/kg/day)-1 and was derived from the female mouse lung (adenoma and/or carcinoma) tumors
来源:Hazardous Substances Data Bank (HSDB)
毒理性
  • 致癌物分类
国际癌症研究机构致癌物:氯菊酯
IARC Carcinogenic Agent:Permethrin
来源:International Agency for Research on Cancer (IARC)
毒理性
  • 致癌物分类
国际癌症研究机构(IARC)致癌物分类:第3组:对其对人类的致癌性无法分类
IARC Carcinogenic Classes:Group 3: Not classifiable as to its carcinogenicity to humans
来源:International Agency for Research on Cancer (IARC)
毒理性
  • 致癌物分类
国际癌症研究机构专著:第53卷:(1991年)杀虫剂应用中的职业暴露及一些农药
IARC Monographs:Volume 53: (1991) Occupational Exposures in Insecticide Application, and Some Pesticides
来源:International Agency for Research on Cancer (IARC)
吸收、分配和排泄
  • 吸收
通过皮肤吸收不良。
Poorly absorbed through the skin.
来源:DrugBank
吸收、分配和排泄
  • 消除途径
permethrin通过酯解迅速代谢为无活性的代谢物,主要通过尿液排出。
Permethrin is rapidly metabolized by ester hydrolysis to inactive metabolites which are excreted primarily in the urine.
来源:DrugBank
吸收、分配和排泄
给泌乳期奶牛(每组三头)喂食不同剂量的permethrin(剂量为0、0.2、1.0、10、50 mg/kg饲料),持续28天,没有出现死亡,生长和产奶都正常。在两个最高剂量平下,3天内牛奶中就观察到了permethrin残留;残留平似乎迅速达到一个平台,并不随时间增加。对单个顺式和反式异构体进行分析显示,牛奶中permethrin异构体的比例在研究过程中似乎发生了变化,顺式异构体占主导。在接受1 mg/kg或更低剂量的动物的组织中没有发现permethrin残留。在10或50 mg/kg的剂量平下,组织中检测到残留物,主要在脂肪中。在最高剂量平下,肌肉和肾脏中也存在低平的残留物。permethrin似乎没有在脂肪中积累,而是迅速达到一个平台。
Lactating cows (three/group) fed permethrin at dose levels of 0, 0.2, 1.0, 10, 50 mg/kg diet for 28 days showed no mortality, and growth and milk production were normal. Permethrin residues were observed in the milk within 3 days at the two highest dietary levels; levels appeared to reach a plateau rapidly and not to increase with time. Analysis of individual cis and trans isomers showed that the ratio of permethrin isomers in milk appeared to change during the course of the study with the cis isomer predominating. Permethrin residues were not found in the tissues of animals that received doses of 1 mg/kg or less. At dose levels of 10 or 50 mg/kg, residues were detected in the tissues, predominantly in the fat. Low levels were also present in the muscle and kidney at the highest dose level. Permethrin did not appear to accumulate in the fat but to reach a plateau rapidly.
来源:Hazardous Substances Data Bank (HSDB)
吸收、分配和排泄
(14)C-顺式-permethrin以1 mg/kg体重的剂量施用于剪毛后的小鼠皮肤上,溶剂为0.1 mL丙酮。小鼠被固定,直到溶剂蒸发,然后放入小鼠代谢笼中。在处理后的1、5、15、50、480和2880分钟时,对小鼠进行牺牲,并检查杀虫剂的吸收、分布和排泄。大约有40%的permethrin在5分钟内从应用部位移动,并似乎迅速转移到身体的其它部位。
(14)C-cis-Permethrin was applied to the clipped skin of mice at a level of 1 mg/kg body weight in 0.1 mL of acetone. The mice were restrained until the solvent had evaporated and then placed in mouse metabolism cages. They were sacrificed at 1, 5, 15, 50, 480, and 2880 min after treatment and examined for absorption, distribution, and excretion of the insecticide. About 40% of the applied permethrin had moved from the site of application within 5 min and appeared to move rapidly to other parts of the body.
来源:Hazardous Substances Data Bank (HSDB)
吸收、分配和排泄
当给哺乳期山羊连续口服十剂(14)C-反式-或(14)C-顺式-氯菊酯(标记在酸或醇部分)剂量为0.2-0.3 mg/kg体重/天时,它们分别通过尿液排出了72-79%和25-36%的反式和顺式异构体剂量,分别通过粪便排出了12-15%。在任何一种四种(14)C标记制剂中,出现在牛奶中的放射性碳量都小于0.7%。关于最后一次给药后24小时内组织的残留物,大部分组织中都发现了可检测平的放射性碳,但对于反式异构体来说,没有超过0.04 mg/kg,对于顺式异构体来说,没有超过0.25 mg/kg。
When ten consecutive oral doses of (14)C-trans- or (14)C-cis- permethrin (labelled in the acid or alcohol moieties) at 0.2-0.3 mg/kg bw/day were given to lactating goats, they excreted 72-79% and 25-36% of the trans and cis isomer doses, respectively, in urine & 12-15%, respectively, in the feces. The amounts of the radiocarbon appearing in the milk were <0.7% with any one of the four (14)C-labelled preparations. Concerning the tissue residues 24 hr after the last dose, detectable levels of radiocarbon were found in most tissue, but none was >0.04 mg/kg for the trans isomer or 0.25 mg/kg for the cis isomer.
来源:Hazardous Substances Data Bank (HSDB)

安全信息

  • 危险品标志:
    Xn,F,T,N
  • 安全说明:
    S13,S16,S24,S26,S36/37,S36/37/39,S45,S60,S61,S7
  • 危险类别码:
    R20/22
  • WGK Germany:
    3
  • 海关编码:
    2916209022
  • 危险品运输编号:
    UN1230 3/PG 2
  • RTECS号:
    GZ1255000
  • 储存条件:
    库房应保持通风、低温和干燥,并且要与氧化剂分开储存和运输。

SDS

SDS:5102783acc302b03dbf3d452dc265b81
查看
第一部分:化学品名称
化学品中文名称: 氯菊酯;二苯醚菊酯
化学品英文名称: Permethrin;Ambush
中文俗名或商品名:
Synonyms:
CAS No.: 52645-53-1
分子式: C 21 H 20 Cl 2 O 3
分子量: 391.31
第二部分:成分/组成信息
化学品 混合物
化学品名称:氯菊酯;二苯醚菊酯
有害物成分 含量 CAS No.
氯菊酯 100 氯菊酯
第三部分:危险性概述
危险性类别: 第6.1类 毒害品
侵入途径: 吸入 食入 经皮吸收
健康危害: 本品属低毒类。对眼睛有轻度刺激作用。对兔皮肤无刺激作用。误服,引起头痛、头晕、恶心、呕吐、流涎和血尿等。严重者出现抽搐和意识障碍。
环境危害: 对环境有危害。
燃爆危险: 本品可燃,具弱刺激性。
第四部分:急救措施
皮肤接触: 用肥皂及清彻底冲洗。就医。
眼睛接触: 拉开眼睑,用流动清冲洗15分钟。就医。
吸入: 脱离现场至空气新鲜处。就医。
食入: 误服者,饮适量温,催吐。洗胃。就医。忌用阿托品
第五部分:消防措施
危险特性: 遇明火、高热可燃。受高热分解,放出有毒的烟气。
有害燃烧产物: 一氧化碳二氧化碳氯化氢
灭火方法及灭火剂: 泡沫、干粉、砂土。
消防员的个体防护: 建议应急处理人员戴自给式呼吸器,穿一般作业工作服。
禁止使用的灭火剂:
闪点(℃): >200
自燃温度(℃):
爆炸下限[%(V/V)]:
爆炸上限[%(V/V)]:
最小点火能(mJ):
爆燃点:
爆速:
最大燃爆压力(MPa):
建规火险分级:
第六部分:泄漏应急处理
应急处理: 迅速撤离泄漏污染区人员至安全区,并进行隔离,严格限制出入。切断火源。建议应急处理人员戴自给式呼吸器,穿一般作业工作服。不要直接接触泄漏物。尽可能切断泄漏源。防止流入下道、排洪沟等限制性空间。小量泄漏:用砂土吸收。大量泄漏:构筑围堤或挖坑收容。用泵转移至槽车或专用收集器内,回收或运至废物处理场所处置。
第七部分:操作处置与储存
操作注意事项: 密闭操作,全面通风。防止蒸气泄漏到工作场所空气中。操作人员必须经过专门培训,严格遵守操作规程。建议操作人员佩戴自吸过滤式防毒面具(半面罩),戴化学安全防护眼镜,穿透气型防毒服,戴防化学品手套。远离火种、热源,工作场所严禁吸烟。使用防爆型的通风系统和设备。在清除液体和蒸气前不能进行焊接、切割等作业。避免产生烟雾。避免与氧化剂、碱类接触。配备相应品种和数量的消防器材及泄漏应急处理设备。倒空的容器可能残留有害物。
储存注意事项: 储存于阴凉、通风的库房。远离火种、热源。防止阳光直射。保持容器密封。应与氧化剂、碱类分开存放,切忌混储。配备相应品种和数量的消防器材。储区应备有泄漏应急处理设备和合适的收容材料。
第八部分:接触控制/个体防护
最高容许浓度: 中 国 MAC:未制订标准前苏联 MAC:未制订标准美国TLV—TWA:未制订标准
监测方法:
工程控制: 生产过程密闭,加强通风。
呼吸系统防护: 空气中浓度超标时,必须佩戴自吸过滤式防毒面具(半面罩)。紧急事态抢救或撤离时,应该佩戴空气呼吸器
眼睛防护: 空气中浓度较高时,佩戴戴化学安全防护眼镜。
身体防护: 穿工作服。
手防护: 一般不需特殊防护。必要时戴防护手套。
其他防护: 工作现场禁止吸烟、进食和饮。工作后,淋浴更衣。注意个人清洁卫生。
第九部分:理化特性
外观与性状: 原药为暗黄色至棕黄色带有结晶的粘稠液体。
pH:
熔点(℃): 35
沸点(℃): 220/0.00665kPa
相对密度(=1): 1.190~1.272(20℃)
相对蒸气密度(空气=1):
饱和蒸气压(kPa):
燃烧热(kJ/mol):
临界温度(℃):
临界压力(MPa):
辛醇/分配系数的对数值:
闪点(℃): >200
引燃温度(℃):
爆炸上限%(V/V):
爆炸下限%(V/V):
分子式: C 21 H 20 Cl 2 O 3
分子量: 391.31
蒸发速率:
粘性:
溶解性: 难溶于,易溶于多数有机溶剂。
主要用途: 农用、卫生用杀虫剂
第十部分:稳定性和反应活性
稳定性: 在常温常压下 稳定
禁配物: 强氧化剂、强碱。
避免接触的条件:
聚合危害: 不能出现
分解产物: 一氧化碳二氧化碳氯化氢
第十一部分:毒理学资料
急性毒性: LD50:>2000mg/kg(大鼠经口);>2000mg/kg(兔经皮) LC50:
急性中毒:
慢性中毒:
亚急性和慢性毒性:
刺激性:
致敏性:
致突变性:
致畸性:
致癌性:
第十二部分:生态学资料
生态毒理毒性:
生物降解性:
生物降解性:
生物富集或生物积累性:
第十三部分:废弃处置
废弃物性质:
废弃处置方法: 建议用控制焚烧法或安全掩埋法处置。掩埋前用碱(石灰)处理。塑料容器要彻底冲洗,不能重复使用。在规定场所掩埋空容器。
废弃注意事项:
第十四部分:运输信息
危险货物编号: 61905
UN编号: 2902
包装标志:
包装类别:
包装方法:
运输注意事项: 路运输时,可以使用塑瓦楞箱作外包装。但须包装试验合格,并经路局批准。运输前应先检查包装容器是否完整、密封,运输过程中要确保容器不泄漏、不倒塌、不坠落、不损坏。严禁与酸类、氧化剂、食品及食品添加剂混运。运输时运输车辆应配备相应品种和数量的消防器材及泄漏应急处理设备。运输途中应防曝晒、雨淋,防高温。公路运输时要按规定路线行驶,勿在居民区和人口稠密区停留。
RETCS号:
IMDG规则页码:
第十五部分:法规信息
国内化学品安全管理法规: 化学危险物品安全管理条例 (1987年2月17日国务院发布),化学危险物品安全管理条例实施细则 (化劳发[1992] 677号),工作场所安全使用化学品规定 ([1996]劳部发423号)等法规,针对化学危险品的安全使用、生产、储存、运输、装卸等方面均作了相应规定;常用危险化学品的分类及标志 (GB 13690-92)将该物质划为第6.1 类毒害品。
国际化学品安全管理法规:
第十六部分:其他信息
参考文献: 1.周国泰,化学危险品安全技术全书,化学工业出版社,1997 2.国家环保局有毒化学品管理办公室、北京化工研究院合编,化学品毒性法规环境数据手册,中国环境科学出版社.1992 3.Canadian Centre for Occupational Health and Safety,CHEMINFO Database.1998 4.Canadian Centre for Occupational Health and Safety, RTECS Database, 1989
填表时间: 年月日
填表部门:
数据审核单位:
修改说明:
其他信息: 5
MSDS修改日期: 年月日

制备方法与用途

毒性

原药对大鼠急性经口LD₅₀为1200~2000 mg/kg,急性吸入LC₅₀>23.5 g/m³(4小时),大鼠和兔急性经皮LD₅₀>2000 mg/kg。对兔皮肤无刺激作用,对眼睛有轻微刺激作用。以1500 mg/kg剂量喂养大鼠6个月未见影响。大鼠体内蓄积性小,动物试验未发现致畸、致癌、致突变作用。

化学性质

纯品为固体,原药为棕黄色黏稠液体或半固体。相对密度1.21(20℃)、1.202(32℃),熔点34~35℃,沸点200℃/1.3 kPa、286℃/常压,不溶于,可溶于多种有机溶剂。在氯化氢存在下,与乙腈反应生成亚乙醚盐酸盐,进一步转化为原乙酸三乙酯。再与转位产物(II)反应得到3,3-二甲基-4,6,6-三己烯-[5]-酸乙酯(V)。在碱性条件下环合为2,2-二甲基-3-(2,2-二乙烯基)环丙烷羧酸乙酯(VII),经皂化反应得相应钠盐,与化间苯氧基苄基三乙胺反应生成氯菊酯。该法原料及中间体较易得到,工艺过程中操作条件要求较严,产品含量一般在60-80%,加工成3.2%或10%乳油、0.25%粉剂使用。

生产方法

三氯乙醛异丁烯合成1,1,1-三-4-甲基-4-戊烯-2-醇,经转位后即得1,1,1-三-4-甲基-3-戊烯-2-醇。再与原乙酸三乙酯缩合重排而得3,3-二甲基-4,6,6-三-5-已烯酸乙酯,进一步在乙醇钠作用下环合为2,2-二甲基-3-(2,2-二乙烯基)环丙烷羧酯乙酯。经皂化成钠盐,再与化间苯氧基苄基三乙胺反应而制得二苯醚菊酯

分类

易燃液体
毒性分级:高毒
急性毒性 - 口服-大鼠 LD₅₀: 383 毫克/公斤;口服-小鼠 LD₅₀: 424 毫克/公斤
刺激数据 - 皮肤-兔子 500 毫克/24小时 轻度
爆炸物危险特性:溶剂蒸气与空气混合可爆
可燃性危险特性:溶剂易燃
储运特性:库房通风低温干燥;与氧化剂分开储运
灭火剂:干粉、泡沫、砂土

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    氯菊酯 在 sodium hydroxide 作用下, 以 甲醇二氯甲烷 为溶剂, 反应 15.0h, 以87.5%的产率得到二氯菊酸
    参考文献:
    名称:
    苄氯菊酯向鱼类中雌激素代谢产物的立体选择性生物转化
    摘要:
    这项研究调查了拟除虫菊酯杀虫剂氯菊酯(PM)的立体选择性生物转化及其所产生的雌激素活性。两者的结果在体内(雄性日本青鳉,在等离子体卵黄蛋白原(VTG)蛋白)和体外(初级虹鳟鱼肝细胞VTG-mRNA表达)检测表明PM的立体选择性雌激素活性。1个小号-顺观察-PM具有显著更高的活性(P ≤0.05)比1 - [R -顺式对映体在两种体内和体外评估。PM的所有对映异构体均被氧化为4'-羟基PM(4OH PM)代谢物,并进行酯酶裂解为3-苯氧基苄醇(3-PBOH)和3-(4'-羟基苯氧基)-苄醇)(3,4' -PBOH)。外消旋4OH PM以及3- PBOH,和3,4'- PBOH具有显著(P ≤0.05)雌激素。1 S-trans -PM比相应的1 R-trans -PM进行了更广泛的酯酶裂解。酮康唑的抑制研究证实了所有立体异构体的细胞色素P450催化的羟基化以及PM的酯酶裂解。这些研究表明,由
    DOI:
    10.1021/tx100167x
  • 作为产物:
    描述:
    2,2-Dimethyl-3-(2,2,2-trichloro-ethyl)-cyclopropanecarboxylic acid 3-phenoxy-benzyl ester 在 1,8-二氮杂双环[5.4.0]十一碳-7-烯 作用下, 以 为溶剂, 以100%的产率得到氯菊酯
    参考文献:
    名称:
    一种实用高效的氟化拟除虫菊酯合成方法。cis-3-(2-Chloro-3,3,3-trifluoro-1-propenyl)-2,2-dimethylcyclopropanecarboxylates
    摘要:
    已开发出一种实用且有效的氟化拟除虫菊酯途径,该途径涉及使用卤醛的分子内烷基化选择性形成顺式环丙烷环,并通过氰醇将醛转化为相应的酯。
    DOI:
    10.1246/cl.1994.703
  • 作为试剂:
    描述:
    4′-氨基乙酰苯胺 、 alkaline earth salt of/the/ methylsulfuric acid 在 氢氧化钾potassium carbonate氯菊酯 作用下, 以 二苯醚乙醇 为溶剂, 反应 72.0h, 生成 N,N,N'-tris(4-methoxyphenyl)-1,4-benzenediamine
    参考文献:
    名称:
    Triamino-s-triazine Triradical Trications. An Experimental Study of Triazine as a Magnetic Coupling Unit
    摘要:
    Triamino-s-triazine derivatives 3a, 4, and 5 have been prepared, and their cationic states have been analyzed electrochemically. At 298 K, 3a(+) has a limited lifetime in CH2CI2 solution, However, 4(+) and 5(+) are long lived under such conditions, and quartet states of 4(3+) and 5(3+) are observed by ESR spectroscopy, Variable temperature ESR analysis and NMR shift susceptibility measurements indicate that 5(3+) is a doublet ground state with a populated quartet state.
    DOI:
    10.1021/ol9912736
点击查看最新优质反应信息

文献信息

  • [EN] ACC INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS DE L'ACC ET UTILISATIONS ASSOCIÉES
    申请人:GILEAD APOLLO LLC
    公开号:WO2017075056A1
    公开(公告)日:2017-05-04
    The present invention provides compounds I and II useful as inhibitors of Acetyl CoA Carboxylase (ACC), compositions thereof, and methods of using the same.
    本发明提供了化合物I和II,这些化合物可用作乙酰辅酶A羧化酶(ACC)的抑制剂,以及它们的组合物和使用方法。
  • [EN] BICYCLYL-SUBSTITUTED ISOTHIAZOLINE COMPOUNDS<br/>[FR] COMPOSÉS ISOTHIAZOLINE SUBSTITUÉS PAR UN BICYCLYLE
    申请人:BASF SE
    公开号:WO2014206910A1
    公开(公告)日:2014-12-31
    The present invention relates to bicyclyl-substituted isothiazoline compounds of formula (I) wherein the variables are as defined in the claims and description. The compounds are useful for combating or controlling invertebrate pests, in particular arthropod pests and nematodes. The invention also relates to a method for controlling invertebrate pests by using these compounds and to plant propagation material and to an agricultural and a veterinary composition comprising said compounds.
    本发明涉及公式(I)中变量如索权和说明中所定义的自行车基取代异噻唑啉化合物。这些化合物对抗或控制无脊椎动物害虫,特别是节肢动物害虫和线虫方面具有用途。该发明还涉及一种通过使用这些化合物来控制无脊椎动物害虫的方法,以及包含所述化合物的植物繁殖材料、农业和兽医组合物。
  • [EN] AZOLINE COMPOUNDS<br/>[FR] COMPOSÉS AZOLINE
    申请人:BASF SE
    公开号:WO2015128358A1
    公开(公告)日:2015-09-03
    The present invention relates to azoline compounds of formula (I) wherein A, B1, B2, B3, G1, G2, X1, R1, R3a, R3b, Rg1 and Rg2 are as defined in the claims and the description. The compounds are useful for combating or controlling invertebrate pests, in particular arthropod pests and nematodes. The invention also relates to a method for controlling invertebrate pests by using these compounds and to plant propagation material and to an agricultural and a veterinary composition comprising said compounds.
    本发明涉及式(I)的噁唑啉化合物,其中A、B1、B2、B3、G1、G2、X1、R1、R3a、R3b、Rg1和Rg2如权利要求和描述中所定义。这些化合物对抗或控制无脊椎动物害虫,特别是节肢动物害虫和线虫方面具有用途。该发明还涉及一种利用这些化合物控制无脊椎动物害虫的方法,以及包括所述化合物的植物繁殖材料、农业和兽医组合物。
  • [EN] MICROBIOCIDAL OXADIAZOLE DERIVATIVES<br/>[FR] DÉRIVÉS D'OXADIAZOLE MICROBIOCIDES
    申请人:SYNGENTA PARTICIPATIONS AG
    公开号:WO2017157962A1
    公开(公告)日:2017-09-21
    Compounds of the formula (I) wherein the substituents are as defined in claim 1, useful as a pesticides, especially fungicides.
    式(I)的化合物,其中取代基如权利要求1所定义,作为杀虫剂特别是杀菌剂有用。
  • Thieno-pyrimidine compounds having fungicidal activity
    申请人:Brewster Kirkland William
    公开号:US20070093498A1
    公开(公告)日:2007-04-26
    The present invention relates to thieno[2,3-d]-pyrimidine compounds having fungicidal activity.
    本发明涉及具有杀真菌活性的噻吩[2,3-d]-嘧啶化合物。
查看更多